55714-2500 NDC - POLLEN-WEEDS (GINKGO BILOBA, HYDRASTIS CANADENSIS, TARAXACUM OFFICINALE, ADRENALINUM , ALETRIS FARINOSA, ALFALFA, ALLIUM CEPA, ANTIMONIUM TARTARICUM, ARSENICUM ALBUM, ARTEMISIA VULGARIS, BAPTISIA TINCTORIA, BELLIS PERENNIS, BERBERIS VULGARIS, BRYONIA, CALLUNA VULGARIS, FLOS, CHELIDONIUM MAJUS, CHENOPODIUM ANTHELMINTICUM, DIOSCOREA VILOSA, EUPHRASIA OFFICINALIS, FAGUS SYLVATICA, FRAXINUS AMERICANA, GELSEMIUM SEMPERVIRENS, HISTAMINUM HYDROCHLORICUM, KALI BICHROMICUM, KALI IODATUM, LACHESIS MUTUS, LILIUM TIGRINUM,)

Drug Information

Product NDC: 55714-2500

Proprietary Name: Pollen-Weeds

Non Proprietary Name: Ginkgo biloba, Hydrastis canadensis, Taraxacum officinale, Adrenalinum , Aletris farinosa, Alfalfa, Allium cepa, Antimonium tartaricum, Arsenicum album, Artemisia vulgaris, Baptisia tinctoria, Bellis perennis, Berberis vulgaris, Bryonia, Calluna vulgaris, flos, Chelidonium majus, Chenopodium anthelminticum, Dioscorea vilosa, Euphrasia officinalis, Fagus sylvatica, Fraxinus americana, Gelsemium sempervirens, Histaminum hydrochloricum, Kali bichromicum, Kali iodatum, Lachesis mutus, Lilium tigrinum,

Active Ingredient(s):
  • 15 [hp_X]/g ALETRIS FARINOSA ROOT;
  • 15 [hp_X]/g ALFALFA;
  • 15 [hp_X]/g ANEMONE PULSATILLA;
  • 15 [hp_X]/g ANTIMONY POTASSIUM TARTRATE;
  • 15 [hp_X]/g ARSENIC TRIOXIDE;
  • 15 [hp_X]/g ARTEMISIA VULGARIS ROOT;
  • 15 [hp_X]/g BAPTISIA TINCTORIA ROOT;
  • 15 [hp_X]/g BELLIS PERENNIS;
  • 15 [hp_X]/g BERBERIS VULGARIS ROOT BARK;
  • 15 [hp_X]/g BRYONIA ALBA ROOT;
  • 15 [hp_X]/g CALLUNA VULGARIS FLOWERING TOP;
  • 15 [hp_X]/g CHELIDONIUM MAJUS;
  • 15 [hp_X]/g DIOSCOREA VILLOSA TUBER;
  • 15 [hp_X]/g DYSPHANIA AMBROSIOIDES;
  • 15 [hp_X]/g ELYMUS REPENS ROOT;
  • 15 [hp_X]/g EPINEPHRINE;
  • 15 [hp_X]/g EUPHRASIA STRICTA;
  • 15 [hp_X]/g FAGUS SYLVATICA NUT;
  • 15 [hp_X]/g FRAXINUS AMERICANA BARK;
  • 15 [hp_X]/g GELSEMIUM SEMPERVIRENS ROOT;
  • 6 [hp_X]/g GINKGO;
  • 6 [hp_X]/g GOLDENSEAL;
  • 15 [hp_X]/g HISTAMINE DIHYDROCHLORIDE;
  • 16 [hp_X]/g JUNIPERUS VIRGINIANA TWIG;
  • 15 [hp_X]/g LACHESIS MUTA VENOM;
  • 15 [hp_X]/g LILIUM LANCIFOLIUM WHOLE FLOWERING;
  • 15 [hp_X]/g LYCOPODIUM CLAVATUM SPORE;
  • 15 [hp_X]/g LYCOPUS VIRGINICUS;
  • 15 [hp_X]/g ONION;
  • 16 [hp_X]/g PARTHENIUM HYSTEROPHORUS;
  • 15 [hp_X]/g PHYTOLACCA AMERICANA ROOT;
  • 15 [hp_X]/g POPULUS BALSAMIFERA LEAF BUD;
  • 15 [hp_X]/g POPULUS TREMULOIDES LEAF;
  • 15 [hp_X]/g POTASSIUM DICHROMATE;
  • 15 [hp_X]/g POTASSIUM IODIDE;
  • 15 [hp_X]/g PTELEA TRIFOLIATA BARK;
  • 15 [hp_X]/g QUERCUS ROBUR NUT;
  • 15 [hp_X]/g ROSA DAMASCENA FLOWERING TOP;
  • 15 [hp_X]/g SALIX NIGRA BARK;
  • 15 [hp_X]/g SAMBUCUS NIGRA FLOWERING TOP;
  • 15 [hp_X]/g SCHOENOCAULON OFFICINALE SEED;
  • 6 [hp_X]/g TARAXACUM OFFICINALE;
  • 15 [hp_X]/g THYROID, UNSPECIFIED;
  • 15 [hp_X]/g TRIFOLIUM PRATENSE FLOWER;
  • 15 [hp_X]/g TRILLIUM ERECTUM ROOT;
  • 16 [hp_X]/g ULMUS RUBRA BARK;
  • 15 [hp_X]/g URTICA URENS;
  • 15 [hp_X]/g USTILAGO MAYDIS;
  • 15 [hp_X]/g WYETHIA HELENIOIDES ROOT;
  • 15 [hp_X]/g XEROPHYLLUM ASPHODELOIDES;
  • 16 [hp_X]/g YUCCA FILAMENTOSA


Administration Route(s): ORAL

Dosage Form(s): PELLET

Pharmacy Class(es):
  • Adrenergic alpha-Agonists [MoA];
  • Adrenergic beta-Agonists [MoA];
  • Allergens [CS];
  • Allergens [CS];
  • Catecholamine [EPC];
  • Catecholamines [CS];
  • Cell-mediated Immunity [PE];
  • Cell-mediated Immunity [PE];
  • Dietary Proteins [CS];
  • Fungal Proteins [CS];
  • Increased Histamine Release [PE];
  • Increased Histamine Release [PE];
  • Increased IgG Production [PE];
  • Non-Standardized Food Allergenic Extract [EPC];
  • Non-Standardized Fungal Allergenic Extract [EPC];
  • Vegetable Proteins [CS];
  • alpha-Adrenergic Agonist [EPC];
  • beta-Adrenergic Agonist [EPC]

Labeler Information

Labeler Name: Newton Laboratories, Inc.
Product Type: HUMAN OTC DRUG
FDA Application Number:
Marketing Category: UNAPPROVED HOMEOPATHIC
Start Marketing Date:1/1/2019

Package Information

No. Package Code Package Description Billing Unit
155714-2500-128 g in 1 BOTTLE, GLASS (55714-2500-1)

NDC Record

Field Name Field Value Definition
PRODUCT NDC55714-2500The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAMEHUMAN OTC DRUGIndicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
PROPRIETARY NAMEPollen-WeedsThe proprietary name also known as the trade name is the name of the product chosen by the medication labeler for marketing purposes.
NON PROPRIETARY NAMEGinkgo biloba, Hydrastis canadensis, Taraxacum officinale, Adrenalinum , Aletris farinosa, Alfalfa, Allium cepa, Antimonium tartaricum, Arsenicum album, Artemisia vulgaris, Baptisia tinctoria, Bellis perennis, Berberis vulgaris, Bryonia, Calluna vulgaris, flos, Chelidonium majus, Chenopodium anthelminticum, Dioscorea vilosa, Euphrasia officinalis, Fagus sylvatica, Fraxinus americana, Gelsemium sempervirens, Histaminum hydrochloricum, Kali bichromicum, Kali iodatum, Lachesis mutus, Lilium tigrinum,The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAMEPELLETThe translation of the dosage form Code submitted by the firm.
ROUTE NAMEORALThe translation of the route code submitted by the firm, indicating route of administration.
START MARKETING DATE1/1/2019This is the date that the labeler indicates was the start of its marketing of the drug product.
MARKETING CATEGORY NAMEUNAPPROVED HOMEOPATHICProduct types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAMENewton Laboratories, Inc.Name of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAMEALETRIS FARINOSA ROOT; ALFALFA; ANEMONE PULSATILLA; ANTIMONY POTASSIUM TARTRATE; ARSENIC TRIOXIDE; ARTEMISIA VULGARIS ROOT; BAPTISIA TINCTORIA ROOT; BELLIS PERENNIS; BERBERIS VULGARIS ROOT BARK; BRYONIA ALBA ROOT; CALLUNA VULGARIS FLOWERING TOP; CHELIDONIUM MAJUS; DIOSCOREA VILLOSA TUBER; DYSPHANIA AMBROSIOIDES; ELYMUS REPENS ROOT; EPINEPHRINE; EUPHRASIA STRICTA; FAGUS SYLVATICA NUT; FRAXINUS AMERICANA BARK; GELSEMIUM SEMPERVIRENS ROOT; GINKGO; GOLDENSEAL; HISTAMINE DIHYDROCHLORIDE; JUNIPERUS VIRGINIANA TWIG; LACHESIS MUTA VENOM; LILIUM LANCIFOLIUM WHOLE FLOWERING; LYCOPODIUM CLAVATUM SPORE; LYCOPUS VIRGINICUS; ONION; PARTHENIUM HYSTEROPHORUS; PHYTOLACCA AMERICANA ROOT; POPULUS BALSAMIFERA LEAF BUD; POPULUS TREMULOIDES LEAF; POTASSIUM DICHROMATE; POTASSIUM IODIDE; PTELEA TRIFOLIATA BARK; QUERCUS ROBUR NUT; ROSA DAMASCENA FLOWERING TOP; SALIX NIGRA BARK; SAMBUCUS NIGRA FLOWERING TOP; SCHOENOCAULON OFFICINALE SEED; TARAXACUM OFFICINALE; THYROID, UNSPECIFIED; TRIFOLIUM PRATENSE FLOWER; TRILLIUM ERECTUM ROOT; ULMUS RUBRA BARK; URTICA URENS; USTILAGO MAYDIS; WYETHIA HELENIOIDES ROOT; XEROPHYLLUM ASPHODELOIDES; YUCCA FILAMENTOSAAn active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 6; 15; 16; 15; 15; 15; 15; 15; 16; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 15; 6; 15; 15; 15; 16; 15; 15; 15; 15; 16 
ACTIVE INGRED UNIT[hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g; [hp_X]/g 
PHARM CLASSESAdrenergic alpha-Agonists [MoA], Adrenergic beta-Agonists [MoA], Allergens [CS], Allergens [CS], Catecholamine [EPC], Catecholamines [CS], Cell-mediated Immunity [PE], Cell-mediated Immunity [PE], Dietary Proteins [CS], Fungal Proteins [CS], Increased Histamine Release [PE], Increased Histamine Release [PE], Increased IgG Production [PE], Non-Standardized Food Allergenic Extract [EPC], Non-Standardized Fungal Allergenic Extract [EPC], Vegetable Proteins [CS], alpha-Adrenergic Agonist [EPC], beta-Adrenergic Agonist [EPC] 

Download Record

Download this NDC record in Text format: Export

Download this NDC record in Excel (CSV) format: Export

Download this NDC record in XML format: Export

This page was last updated on: 2/1/2023